Theralase (TLT.V) traded down -4.55 % during a 24 hours period ending at 03:53 PM Central Europe on Monday 26th. One Theralase stock can currently be bought for about CAD 0.2 on popular exchanges. Current supply of Theralase stocks is 310.5 mn. Theralase has a current market capitalization of CAD 65.2 mn and approximately CAD 108.6 k worth of Theralase was traded on exchanges in the last 24 hours. Since last month end, Theralase has traded 16.67 % up. Simple moving average of last 200 days is at CAD 0.25. The highest price of past 52 weeks was recorded at CAD 0.41 on 04/28/2026. 52 weeks low was at CAD 0.15 on 12/23/2025.
Here is how related stocks have performed in the past 24 hours:
Buffalo Potash (BUFF.V) traded up 1.45 % and now trades at CAD 0.68. Buffalo Potash has a market capitalisation of CAD 76.8 mn.
Arizona Gold & Silver (AZS.V) traded up 4.08 % and now trades at CAD 0.52. Current market capitalisation for Arizona Gold & Silver is CAD 77.7 mn.
Teuton (TUO.V) traded down -0.76 % and now trades at CAD 1.25. Current market capitalisation for Teuton is CAD 77.8 mn. Current price/earnings ratio for Teuton is 81.29.
Transat At (TRZ.TO) traded down -1.05 % and now trades at CAD 1.89. Current market capitalisation for Transat At is CAD 77.5 mn.
Endurance Gold (EDG.V) traded down -2.56 % and now trades at CAD 0.38. Current market capitalisation for Endurance Gold is CAD 76.1 mn.
About Theralase
Theralase Technologies Inc. is a health care equipment and supply company based in Canada with its main operations in Toronto. The company specializes in the design, development, manufacturing, and selling of therapeutic medical lasers for use in photo-dynamic medical therapy. Its areas of focus include pain management, musculo-skeletal arthritic and rheumatoidal disorders, as well as wound care and healing, including bone fractures. You can find more information about the company and its offerings on their website, located at www.theralase.com . The company’s stock is traded on the TSX Venture Exchange.
